Vestal Point Capital, Lp Top Holdings and 13F Report (2026) About Vestal Point Capital, LpInvestment ActivityVestal Point Capital, Lp has $3.87 billion in total holdings as of September 30, 2026.Vestal Point Capital, Lp owns shares of 63 different stocks, but just 15 companies or ETFs make up 80% of its holdings.Approximately 33.03% of the portfolio was purchased this quarter.About 31.68% of the portfolio was sold this quarter.This quarter, Vestal Point Capital, Lp has purchased 68 new stocks and bought additional shares in 23 stocks.Vestal Point Capital, Lp sold shares of 20 stocks and completely divested from 20 stocks this quarter.Largest Holdings Abivax SA $392,119,200Neurocrine Biosciences $354,600,000BioMarin Pharmaceutical $331,500,000Arrowhead Pharmaceuticals $315,141,750Insmed $311,031,500 Largest New Holdings this Quarter 89422G107 - Travere Therapeutics $35,328,000 Holding03969F109 - Arcus Biosciences $33,579,000 Holding10806X102 - BridgeBio Pharma $26,320,000 Holding98985Y108 - Zymeworks Inc $15,894,000 Holding19240Q201 - Cogent Biosciences $15,209,500 Holding Largest Purchases this Quarter Insmed 2,475,000 shares (about $282.50M)Arrowhead Pharmaceuticals 3,240,000 shares (about $212.06M)Abivax SA 1,610,557 shares (about $159.48M)Neurocrine Biosciences 620,000 shares (about $87.94M)Ascendis Pharma A/S 365,000 shares (about $83.16M) Largest Sales this Quarter Zimmer Biomet 925,000 shares (about $82.17M)Insulet 495,000 shares (about $64.58M)Sanofi 1,500,000 shares (about $61.85M)Enliven Therapeutics 775,000 shares (about $35.53M)BioMarin Pharmaceutical 500,000 shares (about $30M) Sector Allocation Over TimeMap of 500 Largest Holdings ofVestal Point Capital, Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorAbivax SA$392,119,200$159,477,354 ▲68.6%3,960,00010.1%SPONSORED ADSNBIXNeurocrine Biosciences$354,600,000$87,940,800 ▲33.0%2,500,0009.2%HealthcareBMRNBioMarin Pharmaceutical$331,500,000$30,000,000 ▼-8.3%5,525,0008.6%HealthcareARWRArrowhead Pharmaceuticals$315,141,750$212,058,000 ▲205.7%4,815,0008.1%HealthcareINSMInsmed$311,031,500$282,496,500 ▲990.0%2,725,0008.0%HealthcareUTHRUnited Therapeutics$257,397,750$21,675,600 ▲9.2%475,0006.6%HealthcareAscendis Pharma A/S$168,594,200$83,157,950 ▲97.3%740,0004.4%ORD SHSNRIXNurix Therapeutics$166,562,750$24,302,750 ▼-12.7%7,025,0004.3%HealthcareTARSTarsus Pharmaceuticals$159,863,261$77,322,761 ▲93.7%2,033,6254.1%HealthcareELVNEnliven Therapeutics$147,834,000$35,526,000 ▼-19.4%3,225,0003.8%HealthcareIRONDisc Medicine$107,027,100$5,564,100 ▲5.5%1,635,0002.8%HealthcareBicara Therapeutics Inc$102,820,250$5,117,750 ▲5.2%5,525,0002.7%COMDyne Therapeutics Inc$99,882,000$45,510,750 ▲83.7%6,200,0002.6%COMIMTXImmatics$98,336,000$44,119,500 ▲81.4%11,200,0002.5%HealthcareTSHATaysha Gene Therapies$87,879,150$6,671,900 ▼-7.1%18,045,0002.3%HealthcareGLUEMonte Rosa Therapeutics$85,060,900$30,182,900 ▲55.0%7,130,0002.2%HealthcareGMEDGlobus Medical$68,533,500$4,868,500 ▲7.6%915,0001.8%HealthcareCrescent Biopharma Inc$43,770,000$19,988,300 ▲84.0%3,000,0001.1%COMZBHZimmer Biomet$42,194,250$82,167,750 ▼-66.1%475,0001.1%HealthcareTVTXTravere Therapeutics$35,328,000$35,328,000 ▲New Holding600,0000.9%HealthcareRCUSArcus Biosciences$33,579,000$33,579,000 ▲New Holding1,300,0000.9%HealthcareXENEXenon Pharmaceuticals$31,611,500$5,578,500 ▲21.4%850,0000.8%HealthcareNektar Therapeutics$30,877,950$29,667,050 ▼-49.0%510,0000.8%COM NEWBright Minds Biosciences Inc$27,151,9000.0%545,0000.7%COM NEWBBIOBridgeBio Pharma$26,320,000$26,320,000 ▲New Holding400,0000.7%HealthcareIMCRImmunocore$25,746,500$28,775,500 ▼-52.8%850,0000.7%HealthcarePODDInsulet$22,832,250$64,582,650 ▼-73.9%175,0000.6%HealthcareTRVITrevi Therapeutics$21,408,400$22,983,600 ▼-51.8%1,495,0000.6%HealthcareSNYSanofi$20,615,000$61,845,000 ▼-75.0%500,0000.5%HealthcareSVRASavara$17,028,000$2,992,800 ▲21.3%3,300,0000.4%HealthcareSpyGlass Pharma Inc$16,640,000$780,000 ▼-4.5%640,0000.4%COM SHSZymeworks Inc$15,894,000$15,894,000 ▲New Holding600,0000.4%COMCOGTCogent Biosciences$15,209,500$15,209,500 ▲New Holding475,0000.4%HealthcareSLDBSolid Biosciences$15,074,550$542,250 ▼-3.5%2,085,0000.4%HealthcareLexeo Therapeutics Inc$14,601,6000.0%4,320,0000.4%COMAvalo Therapeutics Inc$12,264,000$383,250 ▲3.2%800,0000.3%COM NEWZenas Biopharma Inc$10,653,150$809,100 ▲8.2%395,0000.3%COMEvommune Inc$10,325,000$2,065,000 ▲25.0%1,250,0000.3%COM SHSVKTXViking Therapeutics$9,454,000$12,714,000 ▼-57.4%290,0000.2%HealthcareSTOKStoke Therapeutics$8,970,000$8,970,000 ▲New Holding345,0000.2%HealthcareKorsana Biosciences Inc$8,419,360$8,419,360 ▲New Holding263,1050.2%COMDamora Therapeutics Inc$8,405,600$8,405,600 ▲New Holding395,0000.2%COM SHSTectonic Therapeutic Inc$8,384,400$1,513,850 ▼-15.3%360,0000.2%COMZURAZura Bio$7,737,600$2,853,943 ▲58.4%1,860,0000.2%HealthcareGKOSGlaukos$7,388,550$7,388,550 ▲New Holding45,0000.2%HealthcareKailera Therapeutics Inc$7,137,500$571,000 ▲8.7%625,0000.2%COMMON STOCKAnteris Technologies Global Co$6,604,500$1,243,200 ▼-15.8%850,0000.2%COMMLTXMoonLake Immunotherapeutics$6,142,500$6,142,500 ▲New Holding525,0000.2%HealthcareRZLTRezolute$6,023,700$4,438,084 ▲279.9%1,455,0000.2%HealthcareFirst Tracks Biotherapeutics I$6,015,515$29,885,207 ▼-83.2%169,7380.2%ORD SHSVYGRVoyager Therapeutics$5,802,200$1,232,800 ▼-17.5%2,165,0000.1%HealthcareMaze Therapeutics Inc$4,756,500$4,756,500 ▲New Holding175,0000.1%COMOLMAOlema Pharmaceuticals$3,628,800$12,519 ▲0.3%420,0000.1%HealthcarePalisade Bio Inc$3,375,0000.0%2,500,0000.1%COMenGene Therapeutics Inc$3,330,000$4,860 ▼-0.1%1,665,0000.1%COMNeurogene Inc$3,199,300$3,199,300 ▲New Holding115,0000.1%COMiBio Inc$3,068,0000.0%2,600,0000.1%COM NEWArriVent Biopharma Inc$3,028,000$3,028,000 ▲New Holding100,0000.1%COMOnKure Therapeutics Inc$2,964,800$2,010,230 ▼-40.4%1,088,0000.1%COM CL ACTMXCytomX Therapeutics$1,455,200$1,455,200 ▲New Holding535,0000.0%HealthcareOCSOculis$1,232,880$1,232,880 ▲New Holding132,0000.0%HealthcareNYXHNyxoah$661,020$502,956 ▼-43.2%479,0000.0%HealthcareAPREAprea Therapeutics$262,5000.0%350,0000.0%HealthcareABTAbbott Laboratories$0$127,036,000 ▼-100.0%00.0%HealthcareAZNCFAstraZeneca$0$85,329,000 ▼-100.0%00.0%HealthcareRVMDRevolution Medicines$0$84,276,000 ▼-100.0%00.0%HealthcareBCRXBioCryst Pharmaceuticals$0$83,000,000 ▼-100.0%00.0%HealthcareRGENRepligen$0$54,576,000 ▼-100.0%00.0%HealthcareBMYBristol Myers Squibb$0$46,096,000 ▼-100.0%00.0%HealthcareQUREuniQure$0$43,066,100 ▼-100.0%00.0%HealthcareMDGLMadrigal Pharmaceuticals$0$34,901,750 ▼-100.0%00.0%HealthcareALCAlcon$0$33,550,000 ▼-100.0%00.0%HealthcareMYGNMyriad Genetics$0$32,746,850 ▼-100.0%00.0%HealthcareRapport Therapeutics Inc$0$30,419,100 ▼-100.0%00.0%COMGEHCGE HealthCare Technologies$0$28,804,500 ▼-100.0%00.0%HealthcareBeta Bionics Inc$0$25,072,000 ▼-100.0%00.0%COMREGNRegeneron Pharmaceuticals$0$24,941,600 ▼-100.0%00.0%HealthcareAlto Neuroscience Inc$0$20,716,150 ▼-100.0%00.0%COM SHSDamora Therapeutics Inc$0$14,955,750 ▼-100.0%00.0%COM NEWSurrozen Inc$0$7,906,161 ▼-100.0%00.0%COM NEWMonopar Therapeutics Inc$0$7,011,563 ▼-100.0%00.0%COM NEWSagimet Biosciences Inc$0$4,139,044 ▼-100.0%00.0%COM SER ATenax Therapeutics Inc$0$777,537 ▼-100.0%00.0%COM NEWShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.